Full Name:  Ali Mahmoud Taha

E-mail: alytaha@yahoo.com.

Date of birth: 3 October 1938.

• B. Pharm.Sci.: Faculty of Pharmacy, Cairo University, Egypt. June 1959; Grade: Very Good (Honors).

• Diploma of Analysis & Biological Standardization of Drugs. Faculty of Pharmacy, Cairo University, Egypt. November 1961; Grade: Very Good.

• M.Sc. (Pharmaceutical Chemistry). School of Pharmacy, University of Connecticut, Storrs, CT, U.S.A..; May 1965 (Honors).

• Ph.D. (Pharmaceutical Chemistry) School  of Pharmacy, University of Connecticut, Storrs, CT, U.S.A.; June 1966 (Honors).

• Research Grant (N.I.H. GM 07967-04), University of Connecticut, Storrs, CT, U.S.A. “Zone Refining of Ultrapure Antischistosomal Drugs”. 1963-1964.

• Research Fellow, Alexander von Humboldt Stiftung. Institut fur Pharmazeutische Chemie, Munster, W. Germany. Tropane Alkaloids” .1/9/1975 to 30/11/1977.

• Principal Investigator of Research Project (SR 1,650,000) at College of Medicine, King Abd Al-Aziz University, Jeddah, Saudi Arabia; sponsored by King Abd Al-Aziz City for Science & Technology (KACST, Riyadh, Saudi Arabia). “Investigation of Skin Surface Lipids of Saudi Males and Females”. 1982 to 1985.

• Co-Investigator of Research Project (SR 1,050,000) at College of Medicine, King Abd Al-Aziz University, Jeddah, Saudi Arabia; sponsored by King Abd Al-Aziz City for Science & Technology (KACST, Riyadh, Saudi Arabia). “ Isolation of Drugs from Marine Natural Products (Sponges and Algae)”. 1986 to 1988.

• Co-Investigator of Research Project (SR 900,000) at College of Medicine, King Abd Al-Aziz University, Jeddah, Saudi Arabia; sponsored by King Abd Al-Aziz City for Science & Technology (KACST, Riyadh, Saudi Arabia). “ Biochemical Investigation of Hernia in Saudi Patients”. 1988 to 1990.

• Co-Investigator of Research Project (SR 1,000,000) at College of Medicine, King Abd Al-Aziz University, Jeddah, Saudi Arabia; sponsored by King Abd Al-Aziz City for Science & Technology (KACST, Riyadh, Saudi Arabia). “Luteal Phase deficiency in Female Saudi Population”. 1989 to 1991.

• Instructor of Pharmaceutical Chemistry.  Faculty of Pharmacy, Cairo University, Cairo, Egypt.  22/11/1959 to 11/9/1962.

• Member, Egyptian Government Sponsored Mission for Ph.D. School of Pharmacy, University of Connecticut, Storrs, CT, U.S.A. 12/9/1962 to 3/9/1966.

• Research Assistant. School of Pharmacy, University of Connecticut, Storrs, CT, U.S.A. 1/6/1963 to 31/12/1964.

• Research Chemist. Antibiotics Dept., Parke-Davis & Co., Detroit, Michigan, U.S.A.; 4/9/1966  to 1/9/1967.

• Assistant Professor of Pharmaceutical Chemistry. Faculty of Pharmacy, Assiut University, Assiut, Egypt. 29/11/1967 to 8/1/1972.

• Associate Professor of Pharmaceutical Chemistry. Faculty of Pharmacy, Assiut University, Assiut, Egypt. 9/1/1972 to 25/1/1976.

• Professor of Pharmaceutical Chemistry. Faculty of Pharmacy, Assiut University, Assiut, Egypt. 25/1/1976 to  31/1/1980.

• Chairman of Pharmaceutical Chemistry Department . Faculty of Pharmacy, Assiut University, Assiut, Egypt. 20/10/1977 to  1/1/1980.

• Professor of Medical Chemistry. College of Medicine & Allied Sciences, King Abd Al-Aziz University, Jeddah, Saudi Arabia. 20/2/1980 to 9/9/1991.

• Medical Union Pharmaceuticals  August 1993 to May 2012. 

• General Director of Marketing : (MUP) 1993-2002

• VP-Marketing and President of Product Managers & Export Departments 2002 to 2012.

• Professor and Head of Pharmaceutical Chemistry Department, Modern University for Technology and Information (MTI) 01/09/2012 to Date

(1) Taha AM. Synthesis of analogs of usnic acid having potential antibiotic activity. Ph.D. Thesis, University of Connecticut, U.S.A. (1967). Diss Abst 3666B, 68-1412 (1968).

(2) Ibrahim MA, Taha AM. General methods for the determination of glycerol in pharmaceutical preparations. J Pharm Sci UAR, 3:167-180 (1962).

(3) Taha AM. Olfaction: a new dimension in drug action (Review). Egypt Pharm J, 52:138-144 (1970); Chem Abst, 77:108969 (1971).

(4) Taha AM, Gomaa CS. Chromatographic investigation of Japanese rose oil. J Pharm Sci UAR, 12:135-151 (1971); Chem Abst, 77:130488r (1972).

(5) Taha AM, Fadel H, Sina A, Ali F, Shaker W. Spectrophotometric determination of triacetyloleandomycin in pharmaceutical preparations. J Pharm Sci UAR, 12:311-322 (1971); Chem Abst, 77:143832y (1972).

(6) Nour MG, Taha AM. Spectrophotometric determination of salicylamide and sodium gentisate in mixtures. J Pharm Sci UAR, 12:323-331 (1971); Chem Abst, 77:143837d (1972).

(7) Nour MG, Taha AM, Sina A, Shaker W. Differential spectrophotometric assay of chloroxylenols. J Pharm Sci UAR, 12:333-346 (1971); Chem Abst, 77:143850c (1972).

(8) Shokeir AA, Taha AM. Histamine level in the CNS in experimental rabies infection and immunization. Z immun -Forsch, 143:206-208 (1972). [PubMed : 4282798 - indexed for MEDLINE] 

(9) Taha AM, Gomaa CS. Microdetermination of thymol via oxidative coupling. Amer Cosmet Perfum,  87:41-42a (1972); Chem Abst, 78:20104a (1973).

(10) Abou Ouf AA, Taha AM, Saidhom MB. Spectrophotometric analysis of primary aliphatic amines with dichlone. J Pharm Sci (USA), 62:1700-1702 (1973). [PubMed:4752118 - indexed for MEDLINE] 

(11) Taha AM, El-Rabbat NA. Stability-indicating assay of chloral hydrate. Proc XIII Conf Pharm Sci, Cairo, 1-6 (1974).

(12) Taha AM, El-Rabbat NA. Photometric stability-indicating determination of dipyrone. Proc XIII Conf Pharm Sci, Cairo, 15-19 (1974).

(13) Taha AM, Farag HH, Ali RN. Microdetermination of phenols via oxidative coupling. Proc XIII Conf Pharm Sci, Cairo, 27-34 (1974).

(14) Taha AM, Farag HH, Ali RN. Photometric analysis of phenylephrine hydrochloride. Proc XIII Conf Pharm Sci, Cairo, 35-40 (1974).

(15) Taha AM, El-Rabbat NA. Metal chelates in photometric analysis of pharmaceuticals. Proc XIII Conf Pharm Sci, Cairo, 41-43 (1974).

(16) Omar N, El-Rabbat NA, Taha AM, Bayomi S. Correlation analysis of antidepressant activity of new pyrazolium derivatives. Proc XIII Conf Pharm Sci, Cairo, 65-66 (1974).

(17) Taha AM, Omar N, Ammar E, Afifi A, Bayomi S. Synthesis and screening of cyclic benzylhydrazine congeners as antidepressants. J Pharm Sci (USA), 63:395-398 (1974).

(18) Taha AM, Ahmad AKS, Gomma CS, El-Fatatry H. Charge-transfer complexes in alkaloid assay. J Pharm Sci (USA), 63:1853-1857 (1974).

(19) Taha AM, Gomaa CS. Unit-dose assay of tropine alkaloids and their synthetic analogs. J Pharm Sci (USA), 64:1398-1400 (1975).

(20) Taha AM, Omar N, Bayomi S. Synthesis of certain cyclic hydrazine derivatives as potential monoamine oxidase inhibitors. Egypt J Pharm Sci, 16:49-56 (1975).

(21) Taha AM, Gomaa CS. Spectrophotometric analysis of alkaloids with picrolonic acid. J Assoc Off Anal Chem, 59:683-688 (1976). [PubMed : 1270400 - indexed for MEDLINE]

(22) Taha AM, Gomaa CS. Analysis of alkaloid mixtures via charge- transfer complexation. J Pharm Sci (USA), 65:986-991 (1976). [PubMed : 957133 - indexed for MEDLINE]

(23) Taha AM, Rucker G. The use of Pi-acceptors for alkaloid detection on thin-layers. J Chromatogr, 132:165-167 (1977).

(24) Taha AM, Rucker G. Utility of Pi-acceptors in alkaloid assay. Arch Pharm (Weinheim -Germany), 310:485-494 (1977).

(25) Taha AM, Rucker G. Novel detection of alkaloids on thin- layers. Planta Medica, 33:305-306 (1978).

(26) Taha AM, Rucker G. 13C-NMR spectroscopy of tropane alkaloids. J Pharm Sci (USA), 67:775-779 (1978).

(27) Abdel Kader MA,  Taha AM, Sensitive and Specific Determination of N-ethyl drugs. J Pharm Pharmacol , 30 (Suppl.: Brit Pharm Conf ) (1978)

(28) Taha AM, Abdel Kader MA. Selective chromatographic detection of N-ethyl drugs. J Chromatogr, 177:62-65 (1979).

(29) Taha AM, AbdelKader MA, AbdelFattah S. Spectrophotometric analysis of quaternized drugs. Part I. Die Pharmazie, 34: 729-734 (1979).

(30) Taha AM, AbdelKader MA, AbdelFattah S. Spectrophotometric analysis of quaternized drugs. Part II. Die Pharmazie, 35: 93-96 (1980).

(31) Taha AM, El-Rabbat NA. Microdetermination of hydrogen peroxide. Ind J Pharm Sci, 42:8-10 (1980).

(32) Taha AM, El-Rabbat NA, El-Kommos ME. Novel modification of the Fujiwara reaction. J Pharm Belg, 35:107-11 (1980).

(33) Taha AM, El-Rabbat NA, El-Kommos ME. Colorimetric assay of chloramphenicol. Arch Pharm Chem Sci Ed, 8:129-134 (1980).

(34) Taha AM, El-Rabbat NA, AbdelFattah F. Analysis of pethidine by a charge-transfer method. J Pharm Belg, 35:437-444 (1980).

(35) Taha AM, El-Rabbat NA, AbdelFattah F. Spectrophotometric assay of hexamethylenetetramine. Analyst (London), 105:568-574 (1980).

(36) El-Shabouri SR, Taha AM, Hussein SA. Diazotized p-nitroaniline as a novel reagent for the detection of phenothiazines. Die Pharmazie ,37:71-73 (1982); Chem Abst, 96:2055053v (1982).

(37) Taha AM, El-Shabouri SR, Rageh AI. Use of ascorbic acid for the selective determination of tertiary amine drugs. Die Pharmazie 37:489-491 (1982); Chem Abst 97:169012u (1982).

(38) Amer MM, Taha AM, El-Zeany BA, El-Sawy OA. Determination of organic pharmaceuticals with N-bromosuccinimide. Part I. Some pyrazolidinedione derivatives. Analyst (London), 107(1277): 908-915 (1982).

 

(39) Taha AM, Amer MM, El-Shabouri SR, Khashaba PY. Spectrophoto- metric determination of ephedrine hydrochloride and phenyl- ephrine hydrochloride. J Assoc Off Anal Chem, 65:489-898 (1982); Chem Abst, 97:78999e (1982).

(40) El-Zeany BA; Amer MM; Taha AM; El-Sawy-OA. Determination of organic pharmaceuticals with N-bromosuccinimide. Part 3. Some pyrazolone derivatives by direct titration. Analyst (London); 107:1054-1059, Sep, (1982)

(41) Amer MM, Taha AM, El-Zeany BA, El-Sawy OA. Determination of organic pharmaceuticals with N-bromosuccinimide. Part IV. Some pyrazolone derivatives by back-titration. Analyst (London), 107(1279):1272-1278 (1982); Chem Abst, 98:8222t (1983).

(42) Taha AM, El-Shabouri SR, Rageh AI. Improved spectrophotometric determination of tertiary amine drugs using malonic acid/acetic anhydride reagent. Egypt J Pharm Sci, 21 (3-4):363-372, 1980, published (1982); Chem Abst, 98:78229z (1983).

(43) Taha AM, El-Rabbat NA, El-Kommos ME, Refaat IH. Spectrophoto- metric analysis of thioridazine hydrochloride. Egypt J Pharm Sci, 22 (1-4):163-169, 1981, published (1983); Chem Abst, 100:126992b (1984).

(44) Taha Am, El-Zeany BA, Amer MM, El-Sawy OA. The analysis of organic pharmaceuticals with N-bromosuccinimide. Part II. Determination of pyrazolidinedione derivatives in pharmaceutical preparations, Egypt J Pharm Sci, 22: (1-4):47-53 ,1981, published (1983); Chem Abstr, 100:126989f (1984).

(45) Taha AM, El-Rabbat NA, El-Kommos ME, Refaat IH. Rapid spectro- photometric assay of phenothiazine drugs in pharmaceutical preparations. Analyst (London), 108(1293):1500-1505 (1983); Chem Abst, 100:39690h (1984).

(46) Tayeb OS, Taha AM, Potential public health benefits of zamzam water. King Abdulaziz Med J ,  3:9-15 (1984).

(47) El-Shabouri-SR; Hussin-SA; Taha-AM; Imera-KM. Colorimetric determination of certain tertiary amine drugs. Bull Pharm Sci Assiut Univ; 8:120-133, 2, (1985)

(48) Marzouki ZMH, Taha AM, Gomaa KS. Variability in the composition of human skin surface lipids in tropical climates. Trop Geogr Med, 39: (4), 310-317, (1987).

(49) Marzouki ZMH, Taha AM, Gomaa KS. Fatty acid profiles of sebaceous triglycerides by capillary gas chromatography with mass selective detection. J Chromatogr Biomed Appl  425:11-24 (1988).

(50) Marzouki ZMH, Taha AM, Gomaa KS. Effect of long-term exposure to petroleum products on the class composition of human skin surface lipids. Anal Clin Biochem, 25: 92-95 (1988)

(51) Ajabnoor-MA; Tilmisany-AK; Taha-AM; Antonius-A.  Isolation of antibiotic principles from some Red Sea sponges.  Egypt J Pharm Sci; 32: 3-4, 797-815, (1991)

(52) Ajabnoor-MA; Tilmisany-AK; Taha-AM; Antonius-A Effect of Red Sea sponge extracts on blood glucose levels in normal mice. J Ethnopharmacol. , 33(1-2): 103-6 May-Jun (1991)

(53) Ajabnoor-MA; Mokhtar-AM; Rafee-AA; Taha-AM. Defective collagen metabolism in Saudi patients with hernia. Ann Clin Biochem.; 29: ( Pt 4): 430-6(1992).

• 1966 American Chemical Society (Medicinal Chemistry Section) Special  Meeting on Updates in Drug Design, Minneapolis, Minnesota, USA, July 1966

• 1969 Egyptian Pharmaceutical Association Annual Conference on Pharmaceutical Sciences, Cairo, Egypt , Sept. 1969

• 1971 Egyptian Pharmaceutical Association Annual Conference – Attendance and presentation of research paper, Cairo, Egypt, Sept. 1971

• 1972 Egyptian Pharmaceutical Association Annual Conference – Attendance and Monitor of Sessions on Pharmacy Practice, Cairo, Egypt Sept. 1972

• 1973 Annual Congress of Federation International Pharmaceutique (FIP) “International Pharmaceutical Federation” (FIP) Stockholm, Sweden, Sept 1973 .

• 1973 : Royal Pharmaceutical Society Annual Conference 1973, Cambridge, UK, Oct. 1973

• 1974 Egyptian Pharmaceutical Association Annual Conference – Attendance and presentation of research paper, Cairo, Egypt Sept. 1974

• 1975: Alexander von Humboldt Stiftung Annual Meeting, Bonn, Germany, June 1975

• 1976 Annual Congress of  International Pharmaceutical Federation (FIP) Warsaw, Poland , Sept. 1976.

• 1978  Alexander von Humboldt Stiftung Conference on International Academic Relations, Bonn, Germany June 1978.

• 1981 Annual Congress of  International Pharmaceutical Federation (FIP) Vienna Austria , Sept. 1981.

• 1997 : Annual Congress of  International Pharmaceutical Federation (FIP) Vancouver, Canada, Sept. 1997

• 1999 : Annual Congress of  International Pharmaceutical Federation (FIP) Barcelona, Spain, Sept. 1999.

• 2000 : Access-Conference-Organization : Conference on ePharmacy, London, UK, April 2000

• 2001 : Access-Conference-Organization :  Conference  on Cross-Border Pharmaceutical Pricing, London, UK, April 2001

• 2005 : Annual Congress of  International Pharmaceutical Federation (FIP) : Chairman of  Pharmacy Practice Program P1, and Workshop organizer, Cairo, Egypt, Sept 2005

• 2008 : Arab Pharmacists Union Annual Meeting, Control of Cardiovascular Diseases, Presentation of Plenary Lecture on Antioxidants, Aden, Yemen 2008.

• 2009 : Dubai International  Pharmaceuticals and Technologies Conference And Exhibition (DUPHAT) Feb 2009

• 2010: Dubai International  Pharmaceuticals and Technologies Conference And Exhibition (DUPHAT) Feb 2010.

• Pharmaceutical Analysis : Instrumental Methods (UV-Visible, GC; GC-MS)

• Chirality & Drug Action.

• Chronopharmacology and Asthma

• Business Forecasting

• ISO 9000 and GMP Documentation.

• Advanced Statistical Analysis.

HONORS SEMINARS:

• 1999 : Pan African Trading Seminar and Exhibit  “Cross Border Trafficking” (including Pharmaceuticals), Johannesburg, South Africa, July 1999

• 2000: Egyptian Pharmaceutical Associotion :Sources of Drug Information. Plenary Lecture “Surfing The Internet “, Cairo, Egypt , June 2000

• 2001 :, Oxidative Stress & French Paradox, Sanaa, Yemen, March  2001

• 2002 : Egyptian Pharmacists Syndicate Joint Seminars with Ministry of Health : Elements of Aging. Presentation of Plenary Lecture on Aging, Cairo, Egypt, March  2002

• 2003: Free Radical Damage and Antioxidants, Jeddah, Saudi Arabia, December 2003 

• 2006: Multi-mineral Supplements and Treatment of Osteoporosis Amman, Jordan,  Feb 2006

• 1990: Hewlett Packard, Workshop on Computerized Gas Chromatography –Mass Spectrometry of Lipids in Biological Samples

• 1994: Chrono-Pharmacology : Bristol Myers Training Centre, Cairo, Egypt

• 1994: Therapeutic Regimens for Asthma : Bristol Myers Training Centre, Cairo, Egypt

• 1995: Business Forecasting, & Advanced Statistical Analysis, Bristol Myers Training Centre, Cairo, Egypt

• 1998: Chirality & Drug Action. National Organization For Drug Control And Research (NODCAR) June 1998

• 1999: Advanced Pharmaceutical Analysis Workshop: Egyptian Pharmaceutical Association, Nov 1999

• 2000: Access-Conference-Organization : Workshop on ePharmacy, London, UK, April 2000

• 2001: Access-Conference-Organization : Workshop on Cross-Border Pharmaceutical Pricing, Plenary Presentation & Workshop monitoring, London, UK, April 2001

• 2005: Pharmacy Practice Workshop FIP Annual Congress, Cairo, Egypt, Sept. 2005.

•1993 to 2011

Medical Advertising Work Shops

Several Biannual Workshops in Jeddah, KSA; Dubai, UAE; Muscat, Oman; Doha, Qatar; Sanaa, Aden, Taez : Yemen; Tripoli, Libya; Almaty, Kazakhstan.

• Egyptian Syndicate of Pharmacists (1959)

• Egyptian Pharmaceutical Society (1959) (Board of Directors 1973 to 1977)

• Egyptian Chemical Society (1967).

• American Pharmaceutical Association (1963)

• American Chemical Society (Medicinal Chemistry Section) (1964).

• American Honorary Pharmacy and Science Societies (Rho-Chi, Sigma-Xi, Phi-Lambda-Upsilon) (1963).

• Standing Committee (Peer Review Board) for consideration of research activities of candidates for the Associate Professor status (1977-1979).

• Committee of the Egyptian Pharmacopoeia (1976).

• Visiting Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, Khartoum University, Khartoum, Sudan.  29/7/1979 to 29/10/1979

• Professor of Medical Chemistry. College of Medicine & Allied Sciences, King Abd Al-Aziz University, Jeddah, Saudi Arabia. 20/2/1980 to 9/9/1991.

• Medical Union Pharmaceuticals  August 1993 to May 2012

• General Director of Marketing : (MUP) 1993-2002.

• VP-Marketing and President of Product Managers & Export Departments 2002 to 2012.

• Software:  Mastering most current PC software programs and internet browsers plus adequate knowledge and experience with essential Hardware.